Important Safety Information for MinoxiBlend-9
Hair Loss

MinoxiBlend-9

Premium blend of 9 active ingredients including minoxidil, peptides, and growth factors for maximum hair restoration.

What is the FDA-approved use of MinoxiBlend-9?

This premium formula combines:

  • Minoxidil for proven hair regrowth stimulation.
  • Copper peptides for improved hair follicle function.
  • Growth factors and amino acids for enhanced hair strength.
  • Antioxidants to protect hair follicles from damage.

Limitations of Use:

  • Contains ingredients not individually FDA-approved for hair loss.
  • May take 3-6 months to see visible results.
  • Higher risk of allergic reactions due to multiple ingredients.

This premium formulation provides comprehensive hair care but requires careful monitoring for reactions.

Who should not use MinoxiBlend-9?

Do not use this product if:

  • You have cardiovascular disease or uncontrolled blood pressure.
  • You have a history of allergic reactions to topical products.
  • You have scalp irritation, infection, or open wounds.
  • You are pregnant or breastfeeding.
  • You have kidney or liver disease.

How should MinoxiBlend-9 be administered?

Apply 1 mL to affected areas of the scalp twice daily. Massage gently and wash hands after application. Allow complete drying before styling.

Important: Start with once daily application for the first week to assess tolerance, then increase to twice daily if well tolerated.

Side Effects Information

Common Side Effects

Dermatologic

  • Scalp irritation (10% to 15%)
  • Itching (8% to 12%)
  • Redness (6% to 10%)
  • Dry scalp (5% to 8%)
  • Flaking (4% to 7%)

General

  • Initial hair shedding (temporary)

Serious Side Effects

Dermatologic

  • Severe allergic reaction
  • Contact dermatitis
  • Unwanted facial/body hair growth

Cardiovascular

  • Chest pain
  • Rapid heart rate

Neurologic

  • Dizziness or fainting

Contact Information

Reach out to our support team for any questions or assistance.

This is a premium multi-ingredient formula requiring careful monitoring. Please see the full Prescribing Information for complete safety information.